This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Sanofi, Aventis Pharma Deutschland, Gmbh, Genzyme Corporation. Active years: 2004-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,546 
1 out of 330 
1 out of 825 
Years Active: 2004-2026
Title: Hauke Szillat: Innovator in Pharmaceutical Chemistry
Introduction
Hauke Szillat is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of five patents. His work focuses on developing innovative compounds that target specific biological pathways, particularly in the treatment of various diseases.
Latest Patents
Among his latest patents is the invention of isoxazolidines as RIPK1 inhibitors. This patent relates to the use of isoxazolidines in treating diseases and disorders mediated by receptor-interacting protein kinase 1. Another notable patent involves isothiazolopyridine-2-carboxamides, which are designed as pharmaceuticals. These compounds are inhibitors of transglutaminases, particularly transglutaminase 2 (TGM2), and are suitable for treating degenerative joint diseases such as osteoarthritis. The patent also includes processes for preparing these compounds and their pharmaceutical compositions.
Career Highlights
Hauke Szillat has worked with notable companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Genzyme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Szillat has collaborated with esteemed colleagues such as Hans Matter and Martin Lorenz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Hauke Szillat is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of various diseases. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile